Last reviewed · How we verify
Placebo, Oral intake single dose — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo, Oral intake single dose (Placebo, Oral intake single dose) — University Hospital, Angers. This drug has no known mechanism of action.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo, Oral intake single dose TARGET | Placebo, Oral intake single dose | University Hospital, Angers | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo, Oral intake single dose CI watch — RSS
- Placebo, Oral intake single dose CI watch — Atom
- Placebo, Oral intake single dose CI watch — JSON
- Placebo, Oral intake single dose alone — RSS
Cite this brief
Drug Landscape (2026). Placebo, Oral intake single dose — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-oral-intake-single-dose. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab